Davis R M Inc. Sells 5,253 Shares of CME Group Inc. $CME

Davis R M Inc. lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 9.5% during the 1st quarter, HoldingsChannel reports. The fund owned 49,858 shares of the financial services provider’s stock after selling 5,253 shares during the quarter. Davis R M Inc.’s holdings in CME Group were worth $14,726,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Norges Bank acquired a new stake in CME Group in the fourth quarter worth about $1,523,241,000. Victory Capital Management Inc. lifted its position in CME Group by 746.4% during the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after purchasing an additional 1,807,491 shares during the period. Life Cycle Investment Partners Ltd acquired a new position in CME Group during the 4th quarter valued at about $217,656,000. Viking Global Investors LP bought a new position in shares of CME Group in the 2nd quarter valued at about $164,648,000. Finally, Vanguard Group Inc. boosted its stake in shares of CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. UBS Group reduced their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research note on Monday, July 6th. Piper Sandler lowered their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research report on Thursday, June 18th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Twelve analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $292.12.

CME Group Stock Performance

CME stock opened at $249.24 on Thursday. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $90.31 billion, a PE ratio of 21.27, a P/E/G ratio of 2.95 and a beta of 0.25. The business’s 50-day moving average price is $255.87 and its two-hundred day moving average price is $281.51.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.96 earnings per share. As a group, research analysts forecast that CME Group Inc. will post 12.17 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were given a $1.30 dividend. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. CME Group’s payout ratio is currently 44.37%.

Insider Buying and Selling

In related news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The stock was bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This trade represents a 38.62% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by company insiders.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group posted Q2 adjusted earnings of $2.99 per share, topping estimates, while revenue of about $1.71 billion also beat forecasts. The upside was supported by strong hedging demand and active derivatives trading, which reinforced confidence in the company’s core exchange business. Reuters article
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, suggesting momentum remains solid heading into the rest of the year. Quiver Quantitative article
• Positive Sentiment: Trading volumes were strong, with average daily volume near 29.8 million contracts and record market data revenue of $238 million, both of which support the view that CME is benefiting from elevated market activity and pricing power. Seeking Alpha presentation
• Positive Sentiment: Shares also gained support from unusual call-option buying and broader investor interest following the earnings beat, which can reinforce near-term upward momentum. Quiver Quantitative options flow article
• Neutral Sentiment: CEO Terrence Duffy pushed back on market chatter about potential perpetual-futures products, saying clients are not demanding them. That appears to have been a side issue rather than a direct driver of the move. Bloomberg article

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.